Paper
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multip
Published Dec 1, 2015 · S. Giralt, L. Garderet, B. Durie
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
74
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Highly Cited
Study Snapshot
High-dose therapy with autologous hematopoietic cell transplantation is standard for patients relapsing after primary therapy, and allogeneic HCT is appropriate for early relapse after primary therapy with high-risk features.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···
Citations
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···